Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Role of recombinent interleukin-12 as an adjuvant on vaccine-induced immunity in murine Schistosoma mansoni infection.

Abdel-Aaty HE, Ramadan NI, Mahmoud MS, Abdel-Aziz SS, Khalil HM, El-Badawy NM, Khalil HH.

J Egypt Soc Parasitol. 1999;29(1):1-11.

PMID:
12561877
2.
3.

Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.

Rezende CM, Silva MR, Santos IG, Silva GA, Gomes DA, Goes AM.

Immunol Lett. 2011 Dec 30;141(1):123-33. doi: 10.1016/j.imlet.2011.09.003. Epub 2011 Sep 17.

4.
6.

Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni.

Akhiani AA, Nilsson LA, Ouchterlony O.

Infect Immun. 1993 Nov;61(11):4919-24.

7.
8.

Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.

Pinho JM, Cardoso FC, Lopes DO, Pinheiro CS, Caliari MV, Oliveira FM, Leite LC, Oliveira SC.

Parasitology. 2010 Jun;137(7):1079-88. doi: 10.1017/S0031182009991387. Epub 2009 Oct 16.

PMID:
19835649
9.

The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice.

Zouain CS, Gustavson S, Oliveira SC, Azevedo V, Alves JB, Goes AM.

Vaccine. 2000 Dec 8;19(9-10):1218-24.

PMID:
11137260
10.

Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.

Botros SS, Doughty BL, Shaker ZA, Akl MM, Sharmy R, Diab TM, Hassanein HI.

Int J Immunopharmacol. 1996 Dec;18(12):707-18.

PMID:
9172014
11.

Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.

Ewaisha RE, Bahey-El-Din M, Mossallam SF, Amer EI, Aboushleib HM, Khalil AM.

Exp Parasitol. 2014 Oct;145:51-60. doi: 10.1016/j.exppara.2014.07.010. Epub 2014 Aug 1.

PMID:
25092439
12.

Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.

Pacheco LG, Mati VL, Castro TL, Dorella FA, Oliveira SC, Miyoshi A, de Melo AL, Azevedo V.

Parasitol Int. 2008 Dec;57(4):506-8. doi: 10.1016/j.parint.2008.04.010. Epub 2008 Apr 26.

PMID:
18538627
13.

Schistosoma mansoni: melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster.

Soliman MF, El Shenawy NS, El Arabi SE.

Exp Parasitol. 2008 Jun;119(2):291-5. doi: 10.1016/j.exppara.2008.01.013. Epub 2008 Feb 6.

PMID:
18331733
14.

Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine.

Romeih MH, Hassan HM, Shousha TS, Saber MA.

Acta Biochim Biophys Sin (Shanghai). 2008 Apr;40(4):327-38.

16.

Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.

Allam G.

Immunobiology. 2009;214(8):712-27. doi: 10.1016/j.imbio.2008.11.017. Epub 2009 Feb 26.

PMID:
19249123
17.

Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen.

Attallah AM, Attia H, Ismail H, Yones E, El-Nashar EM, Abd El-Kader K, Tabll A, Saad A, Sultan A.

Vaccine. 1999 Jul 16;17(22):2786-91.

PMID:
10438048
18.

Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.

Nyindo M, Kariuki TM, Mola PW, Farah IO, Elson L, Blanton RE, King CL.

Infect Immun. 1999 Feb;67(2):636-42.

20.

Schistosoma mansoni phosphofructokinase: immunolocalization in the tegument and immunogenicity.

Mansour JM, McCrossan MV, Bickle QD, Mansour TE.

Parasitology. 2000 May;120 ( Pt 5):501-11.

PMID:
10840980

Supplemental Content

Support Center